Raymond James Financial Services Advisors Inc. grew its holdings in shares of Senseonics Holdings Inc (NASDAQ:SENS) by 221.4% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 263,562 shares of the company’s stock after buying an additional 181,562 shares during the period. Raymond James Financial Services Advisors Inc. owned 0.21% of Senseonics Holdings worth $474,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also bought and sold shares of the company. Goldman Sachs Group Inc. purchased a new stake in shares of Senseonics Holdings in the second quarter worth $276,000. LMR Partners LLP purchased a new stake in shares of Senseonics Holdings in the second quarter worth $177,000. NEA Management Company LLC grew its stake in shares of Senseonics Holdings by 27.1% in the second quarter. NEA Management Company LLC now owns 33,425,275 shares of the company’s stock worth $60,165,000 after acquiring an additional 7,119,989 shares during the last quarter. ING Groep NV grew its stake in shares of Senseonics Holdings by 87.7% in the second quarter. ING Groep NV now owns 225,833 shares of the company’s stock worth $406,000 after acquiring an additional 105,494 shares during the last quarter. Finally, Renaissance Technologies LLC purchased a new stake in shares of Senseonics Holdings in the first quarter worth $111,000.
A number of brokerages have recently issued reports on SENS. Zacks Investment Research raised Senseonics Holdings from a “sell” rating to a “hold” rating in a report on Tuesday, August 15th. Canaccord Genuity reissued a “buy” rating on shares of Senseonics Holdings in a report on Thursday, September 28th.
In other news, COO Mukul Jain sold 13,115 shares of the firm’s stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $3.25, for a total value of $42,623.75. Following the completion of the sale, the chief operating officer now directly owns 13,115 shares of the company’s stock, valued at approximately $42,623.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
TRADEMARK VIOLATION NOTICE: This piece of content was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark law. The original version of this piece of content can be read at https://ledgergazette.com/2017/11/13/senseonics-holdings-inc-sens-stake-raised-by-raymond-james-financial-services-advisors-inc.html.
Shares of Senseonics Holdings Inc (SENS) opened at $2.70 on Monday. Senseonics Holdings Inc has a 1 year low of $1.26 and a 1 year high of $3.67.
Senseonics Holdings (NASDAQ:SENS) last released its quarterly earnings results on Tuesday, October 31st. The company reported ($0.13) earnings per share for the quarter, meeting the consensus estimate of ($0.13). The firm had revenue of $2.10 million for the quarter, compared to analysts’ expectations of $1.51 million. The business’s revenue was up 425.0% on a year-over-year basis.
Senseonics Holdings Profile
Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.
Receive News & Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.